In a typical reaction, aryl aldehyde (2.0 mmol) is reacted
with hpen (1,2-bis(2-hydroxyphenyl)-1,2-diaminoethane) (2.0
mmol) in DMSO (2.0 mL) to form an imidazolidine
intermediate. In solution, the five-membered ring intermedi-
ates (2a to 2f) are in equilibrium with the corresponding ring-
opened monoimines. Although ring-opened monoimines
become more significant (∼10%) with electron-rich alde-
hydes, the equilibrium favors the five-membered rings in
DMSO solution. The imidazolidine ring formation is sluggish
for indole-3-carboxaldehyde due to its electron-rich character.
However, tosylation of the aldehyde (1f) results in facile
formation of the imidazolidine (2f). A large excess (20 mmol)
of ethyl pyruvate is added to the intermediate mixture and
stirred for 3 h at ambient temperature to give the rearranged
diimines (4a to 4f). Remarkably, only a single diastereomer
The absolute configuration of one of the product diimines
4b was determined by X-ray crystallographic analysis. Figure
1 shows the crystal structure of a square-planar Ni(II)
1
of the mixed diimine was detected by H NMR spectra for
all cases. Although some degree of disproportionation leading
to symmetric diaryl diimines (5) is unavoidable, the desirable
diimines (4a to 4f) can be readily separated by column
chromatography in isolated yields of 52-67% (Table 1). It
Figure 1. Crystal structure of the nickel(II) complex of 4b (ORTEP
diagram with thermal ellipsoids at 30% probability).
complex formed from 4b.6 The crystal structure shows that
the configuration at the quaternary center is R, while that at
the other stereocenter is S when the R,R form of hpen is
used for the synthesis. In the crystal structure, the aryl and
ester groups occupy the axial positions.
Table 1. Stereospecific Synthesis of R-Substituted
syn-R,ꢀ-Diamino Ester Diimines
Hydrolysis of the diimine (4a) gave the corresponding
R-substituted syn-R,ꢀ-diamino ester in 81% yield (Supporting
Information). R,ꢀ-Diamino acids are a special class of vicinal
diamines present in many natural products and biologically
active compounds.5 R-Substituted amino acids are attractive
building blocks for their use as robust analogues of natural
amino acids and as powerful enzyme inhibitors.7 Although
a variety of synthetic methods for making R,ꢀ-diamino acids
or R-substituted amino acids have been reported, it has been
a challenge to synthesize R-substituted R,ꢀ-diamino acids.
Only recently their efficient stereoselective synthesis was
reported through the aza-Henry (nitro-Mannich) reaction.8
Interestingly, the syn/anti selectivity for the aza-Henry
reaction can be controlled by complementary catalysts: a
Ni2-Schiff base catalyst9 provides the anti products, while
a bifunctional organocatalyst10 provides the syn products.
In addition to catalytic C-C bond forming reactions, we
propose that the sigmatropic rearrangements can provide a
highly stereospecific and convergent route to R-substituted
(R,S)-4
entry
Ar
(R,S)-4/(S,S)-5a yield (%)b de (%)a ee (%)c
1
2
3
4
5
6
Ph (a)
12/1
15/1
8/1
5/1
10/1
10/1
60
65
65
58
67
52
>97
>97
>97
>97
>97
>97
>98
>98
>98
>98
>98
>97
4-FC6H4 (b)
C6F5 (c)
4-HOC6H4 (d)
2-furanyl (e)
N-tosyl-3-indolyl (f)
a Determined by 1H NMR analysis of the crude mixture. b Isolated yield
after column chromatography. c Determined by chiral-phase HPLC.
can be seen from Table 1 that the diaza-Cope rearrangement
is highly stereospecific even with pyruvate as with aldehydes
(within the detection limits of NMR for de and HPLC for
ee). Thus, this one-pot reaction allows us to prepare
interesting analogues of natural amino acids such as pheny-
lalanine (4a), tyrosine (4d), and tryptophan (4f) as well as a
variety of unnatural amino acids in enantiomerically pure
form.
(6) Crystal data: C27H24.26Cl2.74FN2NiO4, T ) 150(2) K, orthorhombic,
0.26 × 0.06 × 0.05 mm3, P212121, Z ) 4, n˜calcd ) 1.496 Mg/m3, a )
10.9019(9) Å, b ) 13.4448(11) Å, c ) 18.6462(16) Å, a ) 90°, b ) 90°,
g ) 90°, V ) 2733.0(4) Å3, R1 ) 0.0718, wR2 ) 0.1655 (I > 2s(I)); R1 )
0.1221, wR2 ) 0. 1961 (all data), GOF on F2 ) 1.047.
(4) (a) Na´jera, C.; Sansano, J. M. Chem. ReV. 2007, 107, 4584. (b)
Perdih, A.; Dolenc, M. S. Curr. Org. Chem. 2007, 11, 801. (c) Park, H.;
Kim, K. M.; Lee, A.; Ham, S.; Nam, W.; Chin, J. J. Am. Chem. Soc. 2007,
129, 1518.
(7) For reviews, see: (a) Cativiela, C.; D´ıaz-de-Villegas, M. D. Tetra-
hedron: Asymmetry 2007, 18, 569. (b) Ohfune, Y.; Shinada, T. Eur. J. Org.
Chem. 2005, 5127. (c) Vogt, H.; Bra¨se, S. Org. Biomol.Chem. 2007, 5,
406. For selected examples, see: (d) Dickstein, J. S.; Fennie, M. W.; Norman,
A. L.; Paulouse, B. J.; Kozlowski, M. C. J. Am. Chem. Soc. 2008, 130,
15794. (e) Branca, M.; Gori, D.; Guillot, R.; Alezra, V.; Kouklovsky, C.
J. Am. Chem. Soc. 2008, 130, 5864.
(5) For a review, see: (a) Viso, A.; Ferna´ndez de la Pradilla, R.; Garc´ıa,
A.; Flores, A. Chem. ReV. 2005, 105, 3167. For selected examples, see: (b)
Trost, B. M.; Malhotra, S.; Olson, D. E.; Maruniak, A.; Du Bois, J. J. Am.
Chem. Soc. 2009, 131, 4190. (c) Herna´ndez-Toribio, J.; Arraya´s, R. G.;
Carretero, J. C. J. Am. Chem. Soc. 2008, 130, 16150. (d) Yan, X.-X.; Peng,
Q.; Li, Q.; Zhang, K.; Yao, J.; Hou, X.-L.; Wu, Y.-D. J. Am. Chem. Soc.
2008, 130, 14362. (e) Cutting, G. A.; Stainforth, N. E.; John, M. P.; Kociok-
Kohn, G.; Willis, M. C. J. Am. Chem. Soc. 2007, 129, 10362.
(8) (a) Westermann, B. Angew. Chem., Int. Ed. 2003, 42, 151. (b)
Uraguchi, D.; Koshimoto, K.; Ooi, T. J. Am. Chem. Soc. 2008, 130, 10878.
(9) Chen, Z.; Morimoto, H.; Matsunaga, S.; Shibasaki, M. J. Am. Chem.
Soc. 2008, 130, 2170.
(10) Singh, A.; Johnston, J. N. J. Am. Chem. Soc. 2008, 130, 5866.
Org. Lett., Vol. 11, No. 22, 2009
5259